---
figid: PMC4024346__nihms577761f2
figtitle: Phosphorylation of the activation loop serines on MEK1 and 2 decreases affinity
  for allosteric inhibitors such as trametinib and selumetinib
organisms:
- Homo sapiens
- Mus musculus
- Diaporthe sclerotioides
pmcid: PMC4024346
filename: nihms577761f2.jpg
figlink: /pmc/articles/PMC4024346/figure/F2/
number: F2
caption: Phosphorylation of the activation loop serines on MEK1 and 2 decreases affinity
  for allosteric inhibitors such as trametinib and selumetinib. MEK1 T292 is a phosphorylation
  site for ERK1/2 that negatively regulates MEK1 kinase activity. MEK2 lacks this
  negative feedback regulatory site and is not feedback inhibited by ERK1/2 dependent
  phosphorylation.
papertitle: 'Molecular Pathways: Adaptive Kinome Reprogramming in Response to Targeted
  Inhibition of the BRAF-MEK-ERK Pathway in Cancer.'
reftext: Gary L. Johnson, et al. Clin Cancer Res. ;20(10):2516-2522.
year: ''
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.8670788
figid_alias: PMC4024346__F2
figtype: Figure
organisms_ner:
- Homo sapiens
- Mus musculus
redirect_from: /figures/PMC4024346__F2
ndex: af769695-deb6-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4024346__nihms577761f2.html
  '@type': Dataset
  description: Phosphorylation of the activation loop serines on MEK1 and 2 decreases
    affinity for allosteric inhibitors such as trametinib and selumetinib. MEK1 T292
    is a phosphorylation site for ERK1/2 that negatively regulates MEK1 kinase activity.
    MEK2 lacks this negative feedback regulatory site and is not feedback inhibited
    by ERK1/2 dependent phosphorylation.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - KRAS
  - HRAS
  - NRAS
  - BRAF
  - ZHX2
  - ARAF
  - RAF1
  - MAP2K1
  - MAP2K2
  - NM
  - MAPK1
  - MAPK3
  - ras
  - Hras
  - Kras
  - Rem1
  - Braf
  - Braf-rs1
  - Zhx2
  - Map2k1
  - Map2k2
  - Mapk1
  - Mapk3
  - Trametinib
  - Cancer
  - Cardiomyopathy
  - Noonan syndrome
---
